AICIS Confidential Listings and Hidden CAS Numbers

If you've ever tried to look up an ingredient on the AICIS Inventory and found an entry with no CAS number, no chemical name, just a generic description and a registration number, you haven't hit a broken database. That's a confidential listing, and it exists on purpose. Understanding why it's there, and what to do when you run into one, saves you from a lot of unnecessary worry that your ingredient "isn't covered."

What AICIS actually does

AICIS, the Australian Industrial Chemicals Introduction Scheme, regulates cosmetic ingredients as industrial chemicals. That's a structurally different approach from a per-product notification system like Canada's. Rather than notifying each finished cosmetic product, AICIS works through an Inventory of chemicals that have already been assessed and introduction categories that govern how a new or existing chemical can be brought into the country. Your job as a formulator is generally to confirm the ingredients you're using are appropriately covered under this system, not to file your finished lotion recipe with AICIS directly.

Why some entries are confidential

Chemical manufacturers sometimes have a legitimate commercial interest in not revealing exactly what a specialty ingredient is, especially for genuinely novel compounds where the chemical identity itself represents real research investment. AICIS allows for confidential listings in these cases: the substance is still assessed and still appears on the Inventory, but its identifying details, chemical name, CAS number, sometimes even a plain-language description, are withheld from public view.

This isn't unique to Australia. Confidentiality provisions of some kind exist in most chemical inventory systems worldwide, since without them, companies would have strong incentive to avoid registering novel materials at all.

What this looks like from a formulator's side

You'll typically encounter this when a specialty ingredient supplier, often for something like a peptide complex, a proprietary encapsulated active, or a novel polymer, tells you the material is "AICIS listed" but can't or won't give you a public-facing CAS number that matches an open Inventory search.

That's not automatically a problem, but it does mean you can't independently verify coverage the way you would with an openly listed ingredient. You're relying on the supplier's assurance rather than your own lookup.

How to confirm coverage anyway

• Ask the supplier directly for confirmation of AICIS status. A legitimate supplier selling into the Australian market should be able to provide documentation, sometimes a letter or certificate, confirming the ingredient's Inventory status even if the underlying entry is confidential.
• Ask for the AICIS registration or reference number, if one exists for that listing, separate from the CAS number. This gives you something specific to point to if you're ever asked to demonstrate due diligence.
• Check whether the supplier is the one who holds the confidential listing, since introduction obligations under AICIS generally sit with whoever first introduces the chemical into Australia. If you're a small brand sourcing an already-imported specialty ingredient, the compliance burden for the chemical's introduction itself may sit upstream with your supplier or a distributor, not with you.

A comparison that helps frame it

Situation	What's visible to you
Standard Inventory listing	Full CAS number, chemical name, categories
Confidential listing	Registration number and general description only, sometimes less
Supplier-held confidential ingredient	Supplier's written assurance of coverage, details withheld even from you

Don't let "confidential" mean "unverified"

The instinct to worry when a CAS number is missing is a good one generally, since a missing CAS number often just means sloppy documentation. But a genuinely confidential AICIS listing is a different situation from a supplier who simply hasn't done their homework. The distinguishing feature is that a confidential listing comes with some form of official reference or assurance you can point to, even without the full public detail. If a supplier can't produce anything beyond a verbal claim of AICIS coverage, that's worth pushing on regardless of whether confidentiality is the stated reason.

Where this fits into a broader filing picture

Australia works differently enough from Canada's per-product notification model that it's easy to apply the wrong mental framework to it. Cosmetic Comply's Canada filing flow, matching ingredients to INCI names and CAS numbers and screening against restricted lists, is built around Canada's system today, with the US, EU, and Australia on the way. As that AICIS-specific support develops, the confidential-listing question is exactly the kind of nuance that needs its own handling rather than being forced into a Canada-shaped checklist.